Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 13:36:17 UTC |
---|
Update Date | 2021-09-26 23:08:17 UTC |
---|
HMDB ID | HMDB0254344 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Masitinib |
---|
Description | Masitinib, also known as AB 1010 or kinavet ca-1, belongs to the class of organic compounds known as benzanilides. These are aromatic compounds containing an anilide group in which the carboxamide group is substituted with a benzene ring. They have the general structure RNC(=O)R', where R,R'= benzene. Based on a literature review a significant number of articles have been published on Masitinib. This compound has been identified in human blood as reported by (PMID: 31557052 ). Masitinib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Masitinib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(N=C3NC(=CS3)C3=CN=CC=C3)=C(C)C=C2)CC1 InChI=1S/C28H30N6OS/c1-20-5-10-24(16-25(20)31-28-32-26(19-36-28)23-4-3-11-29-17-23)30-27(35)22-8-6-21(7-9-22)18-34-14-12-33(2)13-15-34/h3-11,16-17,19H,12-15,18H2,1-2H3,(H,30,35)(H,31,32) |
---|
Synonyms | Value | Source |
---|
AB 1010 | ChEBI | AB-1010 | ChEBI | AB1010 | ChEBI | 4-((4-Methylpiperazin-1-yl)methyl)-N-(4-methyl-3-((4-(pyridin-3-yl)-1,3-thiazol-2-yl)amino)phenyl)benzamide | MeSH | Kinavet ca-1 | MeSH | Masatinib | MeSH | Masitinib mesylate | MeSH | Masivet | MeSH | Masitinib | MeSH |
|
---|
Chemical Formula | C28H30N6OS |
---|
Average Molecular Weight | 498.65 |
---|
Monoisotopic Molecular Weight | 498.220180784 |
---|
IUPAC Name | N-(4-methyl-3-{[4-(pyridin-3-yl)-2,3-dihydro-1,3-thiazol-2-ylidene]amino}phenyl)-4-[(4-methylpiperazin-1-yl)methyl]benzamide |
---|
Traditional Name | N-(4-methyl-3-{[4-(pyridin-3-yl)-3H-1,3-thiazol-2-ylidene]amino}phenyl)-4-[(4-methylpiperazin-1-yl)methyl]benzamide |
---|
CAS Registry Number | Not Available |
---|
SMILES | CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(N=C3NC(=CS3)C3=CN=CC=C3)=C(C)C=C2)CC1 |
---|
InChI Identifier | InChI=1S/C28H30N6OS/c1-20-5-10-24(16-25(20)31-28-32-26(19-36-28)23-4-3-11-29-17-23)30-27(35)22-8-6-21(7-9-22)18-34-14-12-33(2)13-15-34/h3-11,16-17,19H,12-15,18H2,1-2H3,(H,30,35)(H,31,32) |
---|
InChI Key | WJEOLQLKVOPQFV-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as benzanilides. These are aromatic compounds containing an anilide group in which the carboxamide group is substituted with a benzene ring. They have the general structure RNC(=O)R', where R,R'= benzene. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Anilides |
---|
Direct Parent | Benzanilides |
---|
Alternative Parents | |
---|
Substituents | - Benzanilide
- Diaminotoluene
- Benzamide
- Benzoic acid or derivatives
- Phenylmethylamine
- Aniline or substituted anilines
- Benzylamine
- Benzoyl
- 2,4-disubstituted 1,3-thiazole
- Aralkylamine
- N-alkylpiperazine
- N-methylpiperazine
- Toluene
- Piperazine
- 1,4-diazinane
- Pyridine
- 1,3-thiazol-2-amine
- Azole
- Thiazole
- Heteroaromatic compound
- Amino acid or derivatives
- Carboxamide group
- Tertiary aliphatic amine
- Tertiary amine
- Secondary carboxylic acid amide
- Organoheterocyclic compound
- Carboxylic acid derivative
- Azacycle
- Secondary amine
- Organonitrogen compound
- Amine
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organooxygen compound
- Organic nitrogen compound
- Organic oxygen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Masitinib,1TMS,isomer #1 | CC1=CC=C(N(C(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)[Si](C)(C)C)C=C1N=C1[NH]C(C2=CC=CN=C2)=CS1 | 4495.3 | Semi standard non polar | 33892256 | Masitinib,1TMS,isomer #1 | CC1=CC=C(N(C(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)[Si](C)(C)C)C=C1N=C1[NH]C(C2=CC=CN=C2)=CS1 | 2868.8 | Standard non polar | 33892256 | Masitinib,1TMS,isomer #1 | CC1=CC=C(N(C(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)[Si](C)(C)C)C=C1N=C1[NH]C(C2=CC=CN=C2)=CS1 | 5683.1 | Standard polar | 33892256 | Masitinib,1TMS,isomer #2 | CC1=CC=C(NC(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)C=C1N=C1SC=C(C2=CC=CN=C2)N1[Si](C)(C)C | 4677.9 | Semi standard non polar | 33892256 | Masitinib,1TMS,isomer #2 | CC1=CC=C(NC(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)C=C1N=C1SC=C(C2=CC=CN=C2)N1[Si](C)(C)C | 3179.2 | Standard non polar | 33892256 | Masitinib,1TMS,isomer #2 | CC1=CC=C(NC(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)C=C1N=C1SC=C(C2=CC=CN=C2)N1[Si](C)(C)C | 5783.5 | Standard polar | 33892256 | Masitinib,2TMS,isomer #1 | CC1=CC=C(N(C(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)[Si](C)(C)C)C=C1N=C1SC=C(C2=CC=CN=C2)N1[Si](C)(C)C | 4378.2 | Semi standard non polar | 33892256 | Masitinib,2TMS,isomer #1 | CC1=CC=C(N(C(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)[Si](C)(C)C)C=C1N=C1SC=C(C2=CC=CN=C2)N1[Si](C)(C)C | 2991.9 | Standard non polar | 33892256 | Masitinib,2TMS,isomer #1 | CC1=CC=C(N(C(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)[Si](C)(C)C)C=C1N=C1SC=C(C2=CC=CN=C2)N1[Si](C)(C)C | 5468.5 | Standard polar | 33892256 | Masitinib,1TBDMS,isomer #1 | CC1=CC=C(N(C(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)[Si](C)(C)C(C)(C)C)C=C1N=C1[NH]C(C2=CC=CN=C2)=CS1 | 4632.9 | Semi standard non polar | 33892256 | Masitinib,1TBDMS,isomer #1 | CC1=CC=C(N(C(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)[Si](C)(C)C(C)(C)C)C=C1N=C1[NH]C(C2=CC=CN=C2)=CS1 | 3112.8 | Standard non polar | 33892256 | Masitinib,1TBDMS,isomer #1 | CC1=CC=C(N(C(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)[Si](C)(C)C(C)(C)C)C=C1N=C1[NH]C(C2=CC=CN=C2)=CS1 | 5723.3 | Standard polar | 33892256 | Masitinib,1TBDMS,isomer #2 | CC1=CC=C(NC(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)C=C1N=C1SC=C(C2=CC=CN=C2)N1[Si](C)(C)C(C)(C)C | 4810.3 | Semi standard non polar | 33892256 | Masitinib,1TBDMS,isomer #2 | CC1=CC=C(NC(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)C=C1N=C1SC=C(C2=CC=CN=C2)N1[Si](C)(C)C(C)(C)C | 3448.8 | Standard non polar | 33892256 | Masitinib,1TBDMS,isomer #2 | CC1=CC=C(NC(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)C=C1N=C1SC=C(C2=CC=CN=C2)N1[Si](C)(C)C(C)(C)C | 5802.6 | Standard polar | 33892256 | Masitinib,2TBDMS,isomer #1 | CC1=CC=C(N(C(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)[Si](C)(C)C(C)(C)C)C=C1N=C1SC=C(C2=CC=CN=C2)N1[Si](C)(C)C(C)(C)C | 4679.8 | Semi standard non polar | 33892256 | Masitinib,2TBDMS,isomer #1 | CC1=CC=C(N(C(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)[Si](C)(C)C(C)(C)C)C=C1N=C1SC=C(C2=CC=CN=C2)N1[Si](C)(C)C(C)(C)C | 3546.6 | Standard non polar | 33892256 | Masitinib,2TBDMS,isomer #1 | CC1=CC=C(N(C(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)[Si](C)(C)C(C)(C)C)C=C1N=C1SC=C(C2=CC=CN=C2)N1[Si](C)(C)C(C)(C)C | 5506.2 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Masitinib GC-MS (Non-derivatized) - 70eV, Positive | splash10-00r2-8963300000-2d593c28d5db8989cb5a | 2021-09-23 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Masitinib GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Masitinib LC-ESI-qTof , Positive-QTOF | splash10-0002-0236920000-165320b13f69ca2a3a29 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Masitinib , positive-QTOF | splash10-0udi-1291000000-f2e2f823b1870c00bb6d | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Masitinib , positive-QTOF | splash10-0002-0236920000-165320b13f69ca2a3a29 | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Masitinib 10V, Positive-QTOF | splash10-0002-0144900000-9c6dbca381a41aae5bf8 | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Masitinib 20V, Positive-QTOF | splash10-014j-0589300000-19a7a8c539240afd7b79 | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Masitinib 40V, Positive-QTOF | splash10-014r-3920000000-6f3dbd39f4906a162402 | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Masitinib 10V, Negative-QTOF | splash10-0002-2401900000-ab941bcb0b26ca88ff2c | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Masitinib 20V, Negative-QTOF | splash10-000b-6826900000-b4896718b46f09d23036 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Masitinib 40V, Negative-QTOF | splash10-0gzc-8900000000-ce88d8a1c827d1451021 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Masitinib 10V, Positive-QTOF | splash10-0002-0001900000-101222712422fd743884 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Masitinib 20V, Positive-QTOF | splash10-0002-0319200000-ece5f888ca4a96242c76 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Masitinib 40V, Positive-QTOF | splash10-01b9-3913300000-db838cfd1ed69e4ec4be | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Masitinib 10V, Negative-QTOF | splash10-0002-0001900000-394dbea5938dd91d535b | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Masitinib 20V, Negative-QTOF | splash10-0002-0216900000-5eee9c5baf9c6b2f4045 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Masitinib 40V, Negative-QTOF | splash10-001l-1323900000-0e4400a5ea70ea7a10c4 | 2021-10-12 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | Not Available |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected but not Quantified | Not Quantified | Not Specified | Not Specified | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB11526 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 8250179 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Masitinib |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 10074640 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 63450 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]
|
---|